Human Amnion-Derived Mesenchymal Stem Cells Promote Osteogenic Differentiation in Human Bone Marrow Mesenchymal Stem Cells by Influencing the ERK1/2 Signaling Pathway

<div>Characterization of third-passage adherent amniotic cells: cells were stained with monoclonal antibodies specific for human CD105, CD90, CD79b, CD44, and CD29 and analyzed by flow cytometry.</div>

Stem Cells International

fig1

Figure 1

Figure 1: Human Amnion-Derived Mesenchymal Stem Cells Promote Osteogenic Differentiation in Human Bone Marrow Mesenchymal Stem Cells by Influencing the ERK1/2 Signaling Pathway 

Figure 1 | Human Amnion-Derived Mesenchymal Stem Cells Promote Osteogenic Differentiation in Human Bone Marrow Mesenchymal Stem Cells by Influencing the ERK1/2 Signaling Pathway 